Peptidomimetic inhibitors of cellular Ras protein processing developed at Merck April 14, 1999 No Comments
TX-1123: a lead PK-inhibitory antitumor agent without mitochondrial toxicity April 13, 1999 No Comments
Parke-Davis team achieves excellent preclinical results with new EGF receptor TK inhibitor April 13, 1999 No Comments
Karenitecin compound BNP-1350, a promising candidate for treating pediatric cancers April 13, 1999 No Comments
Chemical modification of magainin peptide results in effective, nontoxic antitumor compound April 13, 1999 No Comments
D-24851 --a new tubulin-interacting agent with oral activity and improved therapeutic index April 13, 1999 No Comments
RSS